NuVasive (NUVA) Stock Dips Despite Strong Preliminary Q4 Show
Zacks Investment Research | Jan 15, 2020 10:01PM ET
NuVasive, Inc. (NASDAQ:NUVA) announced preliminary revenue results for the fourth quarter and 2019. The company is slated to release its detailed financial results for the same period in late February.
The preliminary figures for revenue growth rate for 2019 are higher than the company’s guidance and have surpassed the Zacks Consensus Estimate. However, this still fails to instill investors’ confidence, which is reflected through a 1.4% dip in the stock price that reached $79.61 on Jan 15 at the closing.
NuVasive expects total revenues of $310 million for the to-be-reported quarter, indicating 8% rise from the year-ago reported figure, on both reported and constant currency (CER) basis. Notably, the company’s guidance is above the Zacks Consensus Estimate of $304 million.
For the year, NuVasive's preliminary figures indicate a year-over-year improvement in total revenues to $1.17 billion, ahead of the company’s guidance of $1.14-$1.16 billion as well as the Zacks Consensus Estimate of $1.16 billion. This suggests 6% rise on a reported basis and a 7% increase at CER.
For 2019, strong uptick in total revenues is expected on robust growth in U.S. Spinal Hardware and international revenues. However, the company expects to witness marginal growth in U.S. Surgical Support revenues.
Segmental Expectations
Preliminary figures for fourth-quarter indicate an expected revenue improvement for both U.S. Spinal Hardware and U.S. Surgical Support segments.
For the quarter, U.S. Spinal Hardware revenues are likely to rise 8% on a reported basis.
U.S. Surgical Support revenues are likely to rise 3% on a reported basis.
Geographically, the company’s international revenues are expected to increase 14% on both reported and CER basis.
Price Performance
Shares of NuVasive have gained 69.8% in the past year compared with the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.